0 Комментарии
0 Поделились
353 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Rare Disease Genetic Testing Market: Next-Generation Genomic Technologies Reshaping HealthcareThe Rare Disease Genetic Testing Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, Rare Disease Genetic Testing Market, offers a holistic view of the market. It examines the market’s structure, growth drivers, competitive landscape,...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
The Future of Genetic Testing: AI Integration, DTC Expansion, and Transformative HealthcareThe ApoE gene test market is on the cusp of a transformative era that will fundamentally redefine how genetic risk is assessed and managed. The convergence of artificial intelligence, direct-to-consumer testing, and personalized medicine is creating a new paradigm where genetic insights become more accessible, actionable, and integrated into routine healthcare. As we look toward 2035 and...0 Комментарии 0 Поделились 244 Просмотры 0 предпросмотр
-
Acromesomelic Dysplasia Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Acromesomelic Dysplasia Market CAGR ValueData Bridge Market Research analyses that the acromesomelic dysplasia market is expected to reach USD 4.43 billion by 2030, which is USD 3 billion in 2022, and is expected to undergo a CAGR of 5% during the forecast period 2023 to 2030. In addition to the market...0 Комментарии 0 Поделились 14 Просмотры 0 предпросмотр
-
Direct-to-Consumer Genetic Testing Market: From Ancestry to Health InsightsA saliva sample collected at home can now become the starting point for a much broader health conversation. Direct-To-Consumer Genetic Testing Market is making genetic information more accessible by allowing consumers to order tests, provide samples without a traditional clinical visit, and receive digitally delivered insights. What began largely around ancestry and traits is increasingly...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Aarskog-Scott Syndrome Treatment Market Size, Share & Forecast 2033According to the latest report published by Data Bridge Market Research, the Aarskog-Scott Syndrome Treatment Market CAGR ValueData Bridge Market Research analyses that the global aarskog-scott syndrome treatment market which was USD 3.01 billion in 2022, is expected to reach USD 4.88 million by 2030, and is expected to undergo a CAGR of 6.20% during the forecast period of 2023 to...0 Комментарии 0 Поделились 523 Просмотры 0 предпросмотр
-
Acromesomelic Dysplasia Market Size, Share, Trends & Forecast 2033According to the latest report published by Data Bridge Market Research, the Acromesomelic Dysplasia Market CAGR ValueData Bridge Market Research analyses that the acromesomelic dysplasia market is expected to reach USD 4.43 billion by 2030, which is USD 3 billion in 2022, and is expected to undergo a CAGR of 5% during the forecast period 2023 to 2030. In addition to the market...0 Комментарии 0 Поделились 684 Просмотры 0 предпросмотр
-
Natera (NTRA) draws a Buy and a $475 target as Roth/MKM bets on cancer residual disease testsRoth/MKM started coverage of Natera, Inc. (NTRA) at Buy with a $475 target, pointing to wider use of its minimal residual disease blood tests, firmer pricing and a 2027 early detection study readout. Roth/MKM started coverage of Natera, Inc. (NTRA) on Friday, October 23, 2026, with a Buy rating and a $475 price target, Investing.com reported. The firm built its case on the company's cancer...0 Комментарии 0 Поделились 844 Просмотры 0 предпросмотр
-
Prenatal and Newborn Genetic Testing Market Forecast 2023–2031 with CAGR AnalysisThe global prenatal and newborn genetic testing market is witnessing remarkable growth due to rising awareness about early disease diagnosis, increasing prevalence of genetic disorders, and advancements in molecular diagnostics technologies. Healthcare providers across developed and emerging economies are increasingly adopting genetic screening solutions to improve maternal and infant...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek